These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25429902)

  • 1. Elevated immune monitoring early after cardiac transplantation is associated with increased plaque progression by intravascular ultrasound.
    Cheng R; Azarbal B; Yung A; Chang DH; Patel JK; Kobashigawa JA
    Clin Transplant; 2015 Feb; 29(2):103-9. PubMed ID: 25429902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction Therapy With Antithymocyte Globulin in Patients Undergoing Cardiac Transplantation Is Associated With Decreased Coronary Plaque Progression as Assessed by Intravascular Ultrasound.
    Azarbal B; Cheng R; Vanichsarn C; Patel JK; Czer LS; Chang DH; Kittleson MM; Kobashigawa JA
    Circ Heart Fail; 2016 Jan; 9(1):e002252. PubMed ID: 26747860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
    J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
    Raichlin E; Bae JH; Kushwaha SS; Lennon RJ; Prasad A; Rihal CS; Lerman A
    J Am Coll Cardiol; 2009 Apr; 53(15):1279-86. PubMed ID: 19358941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years.
    Kobashigawa JA; Tobis JM; Starling RC; Tuzcu EM; Smith AL; Valantine HA; Yeung AC; Mehra MR; Anzai H; Oeser BT; Abeywickrama KH; Murphy J; Cretin N
    J Am Coll Cardiol; 2005 May; 45(9):1532-7. PubMed ID: 15862430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
    Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-intensity interval training on progression of cardiac allograft vasculopathy.
    Nytrøen K; Rustad LA; Erikstad I; Aukrust P; Ueland T; Lekva T; Gude E; Wilhelmsen N; Hervold A; Aakhus S; Gullestad L; Arora S
    J Heart Lung Transplant; 2013 Nov; 32(11):1073-80. PubMed ID: 23906899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined heart and kidney transplantation-Is there a protective effect against cardiac allograft vasculopathy using intravascular ultrasound?
    Sato T; Cheng R; Azarbal B; Kittleson M; Patel J; Czer L; Levine R; Dimbil S; Olymbios M; Anzai T; Kransdorf E; Chang DH; Hamilton MA; Esmailian F; Kobashigawa J
    J Heart Lung Transplant; 2019 Sep; 38(9):956-962. PubMed ID: 31301966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis on coronary angiography is a marker for accelerated cardiac allograft vasculopathy as assessed by intravascular ultrasound.
    Cheng R; Kransdorf EP; Wei J; Patel JK; Kobashigawa JA; Azarbal B
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28786501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
    Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of early atherosclerosis in de novo heart transplant recipients: analysis with intravascular ultrasound-derived radiofrequency analysis.
    König A; Kilian E; Rieber J; Schiele TM; Leibig M; Sohn HY; Reichart B; Klauss V
    J Heart Lung Transplant; 2008 Jan; 27(1):26-30. PubMed ID: 18187083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis.
    Watanabe T; Seguchi O; Yanase M; Fujita T; Murata Y; Sato T; Sunami H; Nakajima S; Kataoka Y; Nishimura K; Hisamatsu E; Kuroda K; Okada N; Hori Y; Wada K; Hata H; Ishibashi-Ueda H; Miyamoto Y; Fukushima N; Kobayashi J; Nakatani T
    Transplantation; 2017 Jun; 101(6):1310-1319. PubMed ID: 27472091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.
    Tuzcu EM; Kapadia SR; Sachar R; Ziada KM; Crowe TD; Feng J; Magyar WA; Hobbs RE; Starling RC; Young JB; McCarthy P; Nissen SE
    J Am Coll Cardiol; 2005 May; 45(9):1538-42. PubMed ID: 15862431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.
    Asleh R; Briasoulis A; Pereira NL; Boilson BA; Edwards BS; Adigun R; Maltais S; Daly RC; Lerman A; Kushwaha SS
    ESC Heart Fail; 2018 Dec; 5(6):1118-1129. PubMed ID: 30019530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients.
    Wu YW; Chen YH; Wang SS; Jui HY; Yen RF; Tzen KY; Chen MF; Lee CM
    J Nucl Med; 2010 Jun; 51(6):906-12. PubMed ID: 20484427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular remodeling 1 year after cardiac transplantation.
    Li H; Tanaka K; Chhabra A; Oeser B; Kobashigawa JA; Tobis JM
    J Heart Lung Transplant; 2007 Jan; 26(1):56-62. PubMed ID: 17234518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.
    Kobashigawa JA; Pauly DF; Starling RC; Eisen H; Ross H; Wang SS; Cantin B; Hill JA; Lopez P; Dong G; Nicholls SJ;
    JACC Heart Fail; 2013 Oct; 1(5):389-99. PubMed ID: 24621971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.